These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advances in biology and therapy of multiple myeloma. Barillé-Nion S; Barlogie B; Bataille R; Bergsagel PL; Epstein J; Fenton RG; Jacobson J; Kuehl WM; Shaughnessy J; Tricot G Hematology Am Soc Hematol Educ Program; 2003; ():248-78. PubMed ID: 14633785 [TBL] [Abstract][Full Text] [Related]
4. Multiple myeloma: new aspects of biology and treatment. Ozaki S; Kosaka M J Med Invest; 1998 Feb; 44(3-4):127-36. PubMed ID: 9597800 [TBL] [Abstract][Full Text] [Related]
5. Biologic and clinical advances in multiple myeloma. Varterasian ML Oncology (Williston Park); 1995 May; 9(5):417-24; discussion 429-30. PubMed ID: 7547203 [TBL] [Abstract][Full Text] [Related]
6. Current therapy for multiple myeloma. Rajkumar SV; Gertz MA; Kyle RA; Greipp PR; Mayo Clin Proc; 2002 Aug; 77(8):813-22. PubMed ID: 12173715 [TBL] [Abstract][Full Text] [Related]
7. Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation. Inamoto Y; Kurahashi S; Imahashi N; Fukushima N; Adachi T; Kinoshita T; Tsushita K; Miyamura K; Naoe T; Sugiura I Am J Hematol; 2009 May; 84(5):283-6. PubMed ID: 19338045 [TBL] [Abstract][Full Text] [Related]
8. Treatment of myeloma. Smith ML; Newland AC QJM; 1999 Jan; 92(1):11-4. PubMed ID: 10209667 [TBL] [Abstract][Full Text] [Related]
9. The role of high-dose chemotherapy in the treatment of multiple myeloma: a controversy. Kyle RA Ann Oncol; 2000; 11 Suppl 1():55-8. PubMed ID: 10707780 [TBL] [Abstract][Full Text] [Related]
10. Current drug therapy for multiple myeloma. Huang YW; Hamilton A; Arnuk OJ; Chaftari P; Chemaly R Drugs; 1999 Apr; 57(4):485-506. PubMed ID: 10235689 [TBL] [Abstract][Full Text] [Related]
11. Novel biologically based therapeutic strategies in myeloma. Gupta D; Hideshima T; Anderson KC Rev Clin Exp Hematol; 2002 Sep; 6(3):301-24. PubMed ID: 12616700 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in the management of multiple myeloma. Kumar L; Verma R; Radhakrishnan VR Natl Med J India; 2010; 23(4):210-8. PubMed ID: 21192514 [TBL] [Abstract][Full Text] [Related]
13. Advances in the autologous and allogeneic transplantation strategies for multiple myeloma. Nishihori T; Alsina M Cancer Control; 2011 Oct; 18(4):258-67. PubMed ID: 21976244 [TBL] [Abstract][Full Text] [Related]
14. Treatment of multiple myeloma. San Miguel JF; Bladé Creixenti J; García-Sanz R Haematologica; 1999 Jan; 84(1):36-58. PubMed ID: 10091392 [TBL] [Abstract][Full Text] [Related]
15. A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma. Mark TM; Guarneri D; Forsberg P; Rossi A; Pearse R; Perry A; Pekle K; Tegnestam L; Greenberg J; Shore T; Gergis U; Mayer S; Van Besien K; Ely S; Jayabalan D; Sherbenou D; Coleman M; Niesvizky R Biol Blood Marrow Transplant; 2017 Jun; 23(6):930-937. PubMed ID: 28285081 [TBL] [Abstract][Full Text] [Related]
16. Breakthroughs in the management of multiple myeloma. Heffner LT; Lonial S Drugs; 2003; 63(16):1621-36. PubMed ID: 12904084 [TBL] [Abstract][Full Text] [Related]
17. Advances in therapy of multiple myeloma. Bladé J; Rosiñol L Curr Opin Oncol; 2008 Nov; 20(6):697-704. PubMed ID: 18841053 [TBL] [Abstract][Full Text] [Related]
18. Recent developments and future directions in the treatment of multiple myeloma. Pichardo D; Singhal S; Mehta J; Rosen S Cancer Biother Radiopharm; 2003 Aug; 18(4):497-511. PubMed ID: 14503944 [TBL] [Abstract][Full Text] [Related]
19. [High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients--single center experience]. Piatkowska-Jakubas B; Wolska-Smoleń T; Mensah-Glanowska P; Hawrylecka D; Szostek M; Walter Z; Skotnicki AB Przegl Lek; 2011; 68(2):78-81. PubMed ID: 21751514 [TBL] [Abstract][Full Text] [Related]